MERCK
MAKING NEWS

NEWSROOM

Keep up with the latest about Merck.

LATEST NEWS
more news

    May 22, 2012
Merck Announces Third-Quarter 2012 Dividend

    May 21, 2012
FDA Approves New Labeling for ISENTRESS® (raltegravir) to Include 156-Week Data Demonstrating Long-Term Efficacy, Safety and Tolerability with ISENTRESS in Combination Therapy in Previously Untreated Adult Patients Infected with HIV-1

    May 16, 2012
Merck to Present at Bank of America Merrill Lynch 2012 Healthcare Conference

 

Featured Presentation

Q4 2011 Merck & Co., Inc. Earnings Conference Call

  • Thursday, February 2, 2012 8:00 a.m. ET

Merck & Co., Inc. at JPMorgan Global Healthcare Conference

  • Tuesday, January 10, 2012 3:00 p.m. PT

See all presentations

Merck CEO calls for innovation-friendly U.S. public policy

In an Op Ed in The Wall Street Journal, Merck president and CEO, Ken Frazier signals concern that U.S. public policy proposals may threaten innovation in the life sciences.

Read more

Fighting River Blindness

Fighting river blindness

Each year, the Merck MECTIZAN® Donation Program reaches more than 80 million people at risk for River Blindness worldwide.

Learn more

Related Information

TRUSTe - Click to Verify   This Web This Web Accessibility icon serves as a link to download eSSENTIAL Accessibility assistive technology software for individuals with physical disabilities. It is being featured as part of a Disability Community Involvement initiative that reflects our commitment to Diversity, Inclusion,Corporate Citizenship and Social Responsibility.